Literature DB >> 15252797

The immunogenicity of the tumor-associated antigen Lewis(y) may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein.

Therese Buskas1, Yanhong Li, Geert-Jan Boons.   

Abstract

A Lewis(y) (Le(y)) tetrasaccharide modified by an artificial aminopropyl spacer was synthesized by a highly convergent approach that employed a levulinoyl ester and a 9-fluorenylmethoxycarbonate for temporary protection of the hydroxy groups and a trichloroethyloxycarbonyl as an amino protecting group. The artificial aminopropyl moiety was modified by a thioacetyl group, which allowed efficient conjugation to keyhole limpet hemocyanin (KLH) modified by electrophilic 4-(maleimidomethyl)cyclohexane-1-carboxylate (MI). Mice were immunized with the KLH-MI-Le(y) antigen. A detailed analysis of sera by ELISA established that a strong immunoglobulin G (IgG) antibody response was elicited against the linker region. The use of a smaller and more flexible 3-(bromoacetamido)propionate for the attachment of Le(y) to KLH not only reduced the IgG antibody response against the linker but also led to a significantly improved immune response against the Le(y) antigen. This study shows that highly antigenic linkers suppress antibody responses to weak antigens such as self-antigens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15252797     DOI: 10.1002/chem.200400074

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  55 in total

Review 1.  Carbohydrate-based cancer vaccines: target cancer with sugar bullets.

Authors:  Chang-Cheng Liu; Xin-Shan Ye
Journal:  Glycoconj J       Date:  2012-06-06       Impact factor: 2.916

2.  Carbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines.

Authors:  Qian Qin; Zhaojun Yin; Philip Bentley; Xuefei Huang
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

3.  Synthesis of an Aminooxy Derivative of the GM3 Antigen and Its Application in Oxime Ligation.

Authors:  Kristopher A Kleski; Mengchao Shi; Matthew Lohman; Gabrielle T Hymel; Vinod K Gattoji; Peter R Andreana
Journal:  J Org Chem       Date:  2020-05-01       Impact factor: 4.354

4.  Robust immune responses elicited by a fully synthetic three-component vaccine.

Authors:  Sampat Ingale; Margreet A Wolfert; Jidnyasa Gaekwad; Therese Buskas; Geert-Jan Boons
Journal:  Nat Chem Biol       Date:  2007-09-02       Impact factor: 15.040

5.  A novel synthetic bipartite carrier protein for developing glycotope-based vaccines.

Authors:  Hsiao-Ling Chiang; Chi-Yu Lin; Fan-Dan Jan; Yaoh-Shiang Lin; Chia-Tse Hsu; Jacqueline Whang-Peng; Leroy F Liu; Shin Nieh; Chun-Cheng Lin; Jaulang Hwang
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

Review 6.  Clustered carbohydrates in synthetic vaccines.

Authors:  Francesco Peri
Journal:  Chem Soc Rev       Date:  2012-12-18       Impact factor: 54.564

7.  Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors.

Authors:  Sampat Ingale; Margreet A Wolfert; Therese Buskas; Geert-Jan Boons
Journal:  Chembiochem       Date:  2009-02-13       Impact factor: 3.164

8.  Synthetic and immunological studies of 5'-N-phenylacetyl sTn to develop carbohydrate-based cancer vaccines and to explore the impacts of linkage between carbohydrate antigens and carrier proteins.

Authors:  Qianli Wang; Sandamali Amarasingha Ekanayaka; Jian Wu; Junping Zhang; Zhongwu Guo
Journal:  Bioconjug Chem       Date:  2008-09-25       Impact factor: 4.774

9.  Chemical synthesis and immunological properties of oligosaccharides derived from the vegetative cell wall of Bacillus anthracis.

Authors:  Mahalakshmi Vasan; Jana Rauvolfova; Margreet A Wolfert; Christine Leoff; Elmar L Kannenberg; Conrad P Quinn; Russell W Carlson; Geert-Jan Boons
Journal:  Chembiochem       Date:  2008-07-21       Impact factor: 3.164

10.  6-O-Branched Oligo-β-glucan-Based Antifungal Glycoconjugate Vaccines.

Authors:  Guochao Liao; Zhifang Zhou; Jun Liao; Luning Zu; Qiuye Wu; Zhongwu Guo
Journal:  ACS Infect Dis       Date:  2015-12-30       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.